BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21503625)

  • 1. Disassociation between left ventricular mechanical and electrical properties in ischemic rat heart after G-CSF treatment.
    Liu HM; Luo T; Zhou X; Cai L; Huang TG; Jiang TM; Li YM
    Cardiovasc Drugs Ther; 2011 Jun; 25(3):203-14. PubMed ID: 21503625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte-colony stimulating factor administration after myocardial infarction in a porcine ischemia-reperfusion model: functional and pathological effects of dose timing.
    Beohar N; Flaherty JD; Davidson CJ; Vidovich M; Singhal S; Rapp JA; Erdogan A; Lee DC; Rammohan C; Brodsky A; Wu E; Pieper K; Virmani R; Bonow RO; Mehta J
    Catheter Cardiovasc Interv; 2007 Feb; 69(2):257-66. PubMed ID: 17253607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction.
    Sugano Y; Anzai T; Yoshikawa T; Maekawa Y; Kohno T; Mahara K; Naito K; Ogawa S
    Cardiovasc Res; 2005 Feb; 65(2):446-56. PubMed ID: 15639484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte colony-stimulating factor prevents reperfusion injury after heart preservation.
    Higuchi T; Yamauchi-Takihara K; Matsumiya G; Fukushima N; Ichikawa H; Kuratani T; Maehata Y; Sawa Y
    Ann Thorac Surg; 2008 Apr; 85(4):1367-73. PubMed ID: 18355530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of G-CSF on cardiac remodeling and arterial hyperplasia in rats.
    Li Y; Fukuda N; Yokoyama S; Kusumi Y; Hagikura K; Kawano T; Takayama T; Matsumoto T; Satomi A; Honye J; Mugishima H; Mitsumata M; Saito S
    Eur J Pharmacol; 2006 Nov; 549(1-3):98-106. PubMed ID: 16979158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sivelestat reduces myocardial ischemia and reperfusion injury in rat hearts even when administered after onset of myocardial ischemia.
    Kambe M; Bessho R; Fujii M; Ochi M; Shimizu K
    Interact Cardiovasc Thorac Surg; 2009 Jun; 8(6):629-34. PubMed ID: 19279053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte colony-stimulating factor attenuates myocardial remodeling and ventricular arrhythmia susceptibility via the JAK2-STAT3 pathway in a rabbit model of coronary microembolization.
    Wang W; Ye S; Zhang L; Jiang Q; Chen J; Chen X; Zhang F; Wu H
    BMC Cardiovasc Disord; 2020 Feb; 20(1):85. PubMed ID: 32066388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial.
    Ince H; Petzsch M; Kleine HD; Eckard H; Rehders T; Burska D; Kische S; Freund M; Nienaber CA
    Circulation; 2005 Aug; 112(9 Suppl):I73-80. PubMed ID: 16159869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage colony-stimulating factor treatment after myocardial infarction attenuates left ventricular dysfunction by accelerating infarct repair.
    Yano T; Miura T; Whittaker P; Miki T; Sakamoto J; Nakamura Y; Ichikawa Y; Ikeda Y; Kobayashi H; Ohori K; Shimamoto K
    J Am Coll Cardiol; 2006 Feb; 47(3):626-34. PubMed ID: 16458148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte colony stimulating factor/macrophage colony stimulating factor improves postinfarct ventricular function by suppression of border zone remodelling in rats.
    Miki T; Miura T; Nishino Y; Yano T; Sakamoto J; Nakamura Y; Ichikawa Y; Ikeda Y; Kobayashi H; Ura N; Shimamoto K
    Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):873-82. PubMed ID: 15659052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte colony-stimulating factor exacerbates cardiac fibrosis after myocardial infarction in a rat model of permanent occlusion.
    Cheng Z; Ou L; Liu Y; Liu X; Li F; Sun B; Che Y; Kong D; Yu Y; Steinhoff G
    Cardiovasc Res; 2008 Dec; 80(3):425-34. PubMed ID: 18676396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid receptor agonist reduces myocardial ischemic injury when administered during early phase of myocardial ischemia.
    Shan Y; Sun S; Yang X; Weil MH; Tang W
    Resuscitation; 2010 Jun; 81(6):761-5. PubMed ID: 20227155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of GM-CSF and G-CSF on infiltration of dendritic cells during early left ventricular remodeling after myocardial infarction.
    Naito K; Anzai T; Sugano Y; Maekawa Y; Kohno T; Yoshikawa T; Matsuno K; Ogawa S
    J Immunol; 2008 Oct; 181(8):5691-701. PubMed ID: 18832728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment.
    Minatoguchi S; Takemura G; Chen XH; Wang N; Uno Y; Koda M; Arai M; Misao Y; Lu C; Suzuki K; Goto K; Komada A; Takahashi T; Kosai K; Fujiwara T; Fujiwara H
    Circulation; 2004 Jun; 109(21):2572-80. PubMed ID: 15123535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotective effects of granulocyte colony-stimulating factor in swine with chronic myocardial ischemia.
    Hasegawa H; Takano H; Iwanaga K; Ohtsuka M; Qin Y; Niitsuma Y; Ueda K; Toyoda T; Tadokoro H; Komuro I
    J Am Coll Cardiol; 2006 Feb; 47(4):842-9. PubMed ID: 16487854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte colony stimulating factor in the treatment of cardiac ischemic disease. A decade has passed: is it time to give up? : editorial to "disassociation between left ventricular mechanical and electrical properties in ischemic rat heart after g-csf treatment" by Liu et al.
    Louzada RA; Werneck-de-Castro JP
    Cardiovasc Drugs Ther; 2011 Jun; 25(3):191-5. PubMed ID: 21629987
    [No Abstract]   [Full Text] [Related]  

  • 17. Granulocyte colony-stimulating factor improves early remodeling in isoproterenol-induced cardiac injury in rats.
    Forechi L; Baldo MP; Meyerfreund D; Mill JG
    Pharmacol Rep; 2012; 64(3):643-9. PubMed ID: 22814018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody to granulocyte macrophage colony-stimulating factor reduces the number of activated tissue macrophages and improves left ventricular function after myocardial infarction in a rat coronary artery ligation model.
    Kellar RS; Lancaster JJ; Thai HM; Juneman E; Johnson NM; Byrne HG; Stansifer M; Arsanjani R; Baer M; Bebbington C; Flashner M; Yarranton G; Goldman S
    J Cardiovasc Pharmacol; 2011 May; 57(5):568-74. PubMed ID: 21326109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early use of granulocyte colony stimulating factor improves survival in a rabbit model of chronic myocardial ischemia.
    Zhao Q; Sun C; Xu X; Zhou J; Wu Y; Tian Y; Ma A; Liu Z
    J Cardiol; 2013 Jan; 61(1):87-94. PubMed ID: 23085036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
    Woo YJ; Grand TJ; Berry MF; Atluri P; Moise MA; Hsu VM; Cohen J; Fisher O; Burdick J; Taylor M; Zentko S; Liao G; Smith M; Kolakowski S; Jayasankar V; Gardner TJ; Sweeney HL
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):321-9. PubMed ID: 16077394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.